Journal article
Empowering Older Antibiotics
Abstract
Avycaz combines an older cephalosporin antibiotic, ceftazidime, and the β-lactamase inhibitor avibactam. Ceftazidime targets penicillin-binding proteins (PBPs) in the bacterial periplasm that are required for cell wall synthesis. Avibactam blocks β-lactamases (β-L) in the periplasm, which would otherwise inactivate the antibiotics resulting in drug resistance.
Authors
Wright GD
Journal
Cell, Vol. 167, No. 2,
Publisher
Elsevier
Publication Date
October 2016
DOI
10.1016/j.cell.2016.09.032
ISSN
0092-8674